These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 7834216)

  • 1. Muscarinic (M1) receptor-mediated inhibition of K(+)-evoked [3H]-noradrenaline release from human neuroblastoma (SH-SY5Y) cells via inhibition of L- and N-type Ca2+ channels.
    McDonald RL; Vaughan PF; Peers C
    Br J Pharmacol; 1994 Oct; 113(2):621-7. PubMed ID: 7834216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of L- and N-type Ca2+ channels in muscarinic receptor-mediated facilitation of ACh and noradrenaline release in the rat urinary bladder.
    Somogyi GT; Zernova GV; Tanowitz M; de Groat WC
    J Physiol; 1997 Mar; 499 ( Pt 3)(Pt 3):645-54. PubMed ID: 9130161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of protein kinase C activation on muscarinic-M3- and K(+)-evoked release of [3H]noradrenaline and increases in intracellular Ca2+ in human neuroblastoma SH-SY5Y cells.
    Murphy NP; McCormack JG; Ball SG; Vaughan PF
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):645-50. PubMed ID: 1554348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarine inhibits omega-conotoxin-sensitive calcium channels in a voltage- and time-dependent mode in the human neuroblastoma cell line SH-SY5Y.
    Toselli M; Perin P; Taglietti V
    J Neurophysiol; 1995 Oct; 74(4):1730-41. PubMed ID: 8989408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of N-type Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by muscarine via stimulation of M3 receptors.
    Reeve HL; Vaughan PF; Peers C
    Neuropharmacology; 1995 Mar; 34(3):319-26. PubMed ID: 7630487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M2 muscarinic receptor-mediated inhibition of the Ca2+ current in rat magnocellular cholinergic basal forebrain neurones.
    Allen TG; Brown DA
    J Physiol; 1993 Jul; 466():173-89. PubMed ID: 8410690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptor activation modulates Ca2+ channels in rat intracardiac neurons via a PTX- and voltage-sensitive pathway.
    Jeong SW; Wurster RD
    J Neurophysiol; 1997 Sep; 78(3):1476-90. PubMed ID: 9310437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of depolarisation-evoked [(3)H]noradrenaline release from SH-SYFY human neuroblastoma cells by muscarinic (M1) receptors is not mediated by changes in [Ca(2+)].
    Roberts DJ; Khan N; McDonald RL; Webster NJ; Peers C; Vaughan PF
    Brain Res Mol Brain Res; 2001 Feb; 87(1):81-91. PubMed ID: 11223162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and functional characterization of muscarinic receptors in the frog pars intermedia.
    Garnier M; Lamacz M; Galas L; Lenglet S; Tonon MC; Vaudry H
    Endocrinology; 1998 Aug; 139(8):3525-33. PubMed ID: 9681504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel currents in undifferentiated human neuroblastoma (SH-SY5Y) cells: actions and possible interactions of dihydropyridines and omega-conotoxin.
    Reeve HL; Vaughan PF; Peers C
    Eur J Neurosci; 1994 Jun; 6(6):943-52. PubMed ID: 7952281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential coupling of muscarinic receptors to Ca2+ mobilization and cyclic AMP in SH-SY5Y and IMR 32 neuroblastoma cells.
    Heikkilä J; Jansson C; Akerman KE
    Eur J Pharmacol; 1991 Sep; 208(1):9-15. PubMed ID: 1657623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of calcium channel antagonists on the release of [3H]noradrenaline in the human neuroblastoma, SH-SY5Y.
    Murphy NP; Ball SG; Vaughan PF
    Neurosci Lett; 1991 Aug; 129(2):229-32. PubMed ID: 1745405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs).
    Taglialatela M; Secondo A; Fresi A; Rosati B; Pannaccione A; Castaldo P; Giorgio G; Wanke E; Annunziato L
    Biochem Pharmacol; 2001 Nov; 62(9):1229-38. PubMed ID: 11705456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
    Connor M; Yeo A; Henderson G
    Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of pertussis toxin-sensitive and -insensitive mechanisms in alpha-adrenoceptor modulation of noradrenaline release from rat sympathetic neurones in tissue culture.
    Hill CE; Powis DA; Hendry IA
    Br J Pharmacol; 1993 Sep; 110(1):281-8. PubMed ID: 8106104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the putative P-type calcium channel blocker, R,R-(-)-daurisoline on neurotransmitter release.
    Waldmeier PC; Wicki P; Fröstl W; Bittiger H; Feldtrauer JJ; Baumann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):670-8. PubMed ID: 9053740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum.
    Dobrev D; Milde AS; Andreas K; Ravens U
    Br J Pharmacol; 1999 May; 127(2):576-82. PubMed ID: 10385261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M4 muscarinic receptor activation modulates calcium channel currents in rat intracardiac neurons.
    Cuevas J; Adams DJ
    J Neurophysiol; 1997 Oct; 78(4):1903-12. PubMed ID: 9325359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etomidate inhibits [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells.
    Sikand KS; Hirota K; Smith G; Lambert DG
    Neurosci Lett; 1997 Oct; 236(2):87-90. PubMed ID: 9404818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin-evoked release of [3H]noradrenaline from the human neuroblastoma SH-SY5Y.
    McDonald RL; Kaye DF; Reeve HL; Ball SG; Peers C; Vaughan PF
    Biochem Pharmacol; 1994 Jul; 48(1):23-30. PubMed ID: 8043027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.